Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Guidelines
  • Published:

Testing guidelines for hereditary non-polyposis colorectal cancer

Abstract

Hereditary non-polyposis colorectal cancer is almost always associated with microsatellite instability, so what is the best way to identify the disorder at an early-stage, and what should the next step be in preventing the development of colorectal cancer? Different clinical and molecular diagnostic guidelines have recently been proposed in the context of recent scientific advances, but how are these criteria interpreted and modified across the world?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Role of mismatch repair in maintaining microsatellite sequences.
Figure 2: Strategy for genetic testing of affected individuals from families with suspected hereditary non-polyposis colorectal cancer.

Similar content being viewed by others

References

  1. Lynch, H. T., Shaw, M. W., Manguson, C. W., Larsen, A. L. & Krush, A. J. Hereditary factors in cancer. Arch. Intern. Med. 117, 206–212 (1966).

    Article  CAS  PubMed  Google Scholar 

  2. Warthin, A. S. Hereditary with reference to carcinoma. Arch. Intern. Med. 12, 546–555 (1913).

    Article  Google Scholar 

  3. Vasen, H. F., Watson, P., Mecklin, J. P. & Lynch, H. T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116, 1453–1456 (1999).

    Article  CAS  PubMed  Google Scholar 

  4. Moslein, G. Clinical implications of molecular diagnosis in hereditary nonpolyposis colorectal cancer. Recent Results Cancer Res. 162, 73–78 (2003).

    Article  PubMed  Google Scholar 

  5. Lynch, H. T. & de la Chapelle, A. Genetic susceptibility to non-polyposis colorectal cancer. J. Med. Genet. 36, 801–818 (1999).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Umar, A. et al. Revised Bethesda guidelines for hereditary non-polyposis colorectal cancer and microsatellite instability. J. Natl Cancer Inst. (in the press).

  7. Winawer, S. et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale — update based on new evidence. Gastroenterology 124, 544–560 (2003).

    Article  PubMed  Google Scholar 

  8. Giardiello, F. M., Brensinger, J. D. & Petersen, G. M. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 121, 198–213 (2001).

    Article  CAS  PubMed  Google Scholar 

  9. Lynch, H. T. Hereditary nonpolyposis colorectal cancer (HNPCC). Cytogenet. Cell Genet. 86, 130–135 (1999).

    Article  CAS  PubMed  Google Scholar 

  10. Vasen, H. F., Mecklin, J. P., Khan, P. M. & Lynch, H. T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum 34, 424–425 (1991).

    Article  CAS  PubMed  Google Scholar 

  11. Boland, C. R. & Troncale, F. J. Familial colonic cancer without antecedent polyposis. Ann. Intern. Med. 100, 700–701 (1984).

    Article  CAS  PubMed  Google Scholar 

  12. Leach, F. S. et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215–1225 (1993).

    Article  CAS  PubMed  Google Scholar 

  13. Nicolaides, N. C. et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371, 75–80 (1994).

    Article  CAS  PubMed  Google Scholar 

  14. Papadopoulos, N. et al. Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625–1629 (1994).

    Article  CAS  PubMed  Google Scholar 

  15. Fishel, R. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027–1038 (1993).

    Article  CAS  PubMed  Google Scholar 

  16. Kolodner, R. D. et al. Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 59, 5068–5074 (1999).

    CAS  PubMed  Google Scholar 

  17. Liu, B. et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med. 2, 169–174 (1996).

    Article  CAS  PubMed  Google Scholar 

  18. Peltomaki, P. DNA mismatch repair gene mutations in human cancer. Environ. Health Perspect. 105, S775–S780 (1997).

    Google Scholar 

  19. Herman, J. G. et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA 95, 6870–6875 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ouyang, H. et al. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res. 57, 1851–1854 (1997).

    CAS  PubMed  Google Scholar 

  21. Kuismanen, S. A. et al. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am. J. Pathol. 160, 1953–1958 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Myeroff, L. L. et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55, 5545–5547 (1995).

    CAS  PubMed  Google Scholar 

  23. Thomas, G. & Olschwang, S. Genetic predispositions to colorectal cancer. Pathol. Biol. 43, 159–164 (1995).

    CAS  PubMed  Google Scholar 

  24. Lynch, H. T. et al. Hereditary nonpolyposis colorectal cancer: Lynch syndromes I and II. Gastroenterol. Clin. North Am. 17, 679–712 (1988).

    CAS  PubMed  Google Scholar 

  25. Bhattacharyya, N. P., Skandalis, A., Ganesh, A., Groden, J. & Meuth, M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl Acad. Sci. USA 91, 6319–6323 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Glaab, W. E. et al. Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus. Carcinogenesis 19, 1931–1937 (1998).

    Article  CAS  PubMed  Google Scholar 

  27. Shibata, D. Molecular tumour clocks and colorectal cancer: seeing the unseen. Pathology 34, 534–540 (2002).

    CAS  PubMed  Google Scholar 

  28. Berg, K. D. et al. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J. Mol. Diagn. 2, 20–28 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lindor, N. M. et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J. Clin. Oncol. 20, 1043–1048 (2002).

    Article  CAS  PubMed  Google Scholar 

  30. Ahlquist, D. A. et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119, 1219–1227 (2000).

    Article  CAS  PubMed  Google Scholar 

  31. Rodriguez-Bigas, M. A. et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J. Natl Cancer Inst. 89, 1758–1762 (1997).

    Article  CAS  PubMed  Google Scholar 

  32. Syngal, S., Fox, E. A., Eng, C., Kolodner, R. D. & Garber, J. E. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J. Med. Genet. 37, 641–645 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Cai, S. J. et al. Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer. World J. Gastroenterol. 9, 284–287 (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Anderson, W. F., Umar, A. & Brawley, O. W. Colorectal carcinoma in black and white race. Cancer Metastasis Rev. 22, 67–82 (2003).

    Article  PubMed  Google Scholar 

  35. Lipton, L. et al. Germline mutations in the TGF-β and Wnt signalling pathways are a rare cause of the 'multiple' adenoma phenotype. J. Med. Genet. 40, e35 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Liu, B. et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res. 54, 4590–4594 (1994).

    CAS  PubMed  Google Scholar 

  37. Lin, K. M. et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J. Gastrointest. Surg. 2, 67–71 (1998).

    Article  CAS  PubMed  Google Scholar 

  38. Kunitomo, K. et al. HNPCC in Japan. Anticancer Res. 12, 1856–1857 (1992).

    Google Scholar 

  39. Han, H. J. et al. Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J. Natl Cancer Inst. 88, 1317–1319 (1996).

    Article  CAS  PubMed  Google Scholar 

  40. Yuan, Y. & Zheng, S. Screening Criteria of HNPCC in China (Meeting report). Zhonghua Zhongliu Zazhi 25 (in the press).

Download references

Acknowledgements

The authors would like to acknowledge the participants of the National Cancer Institute Diagnostic Criteria for Hereditary non-Polyposis Colorectal Cancer and Microsatellite Instability meeting, which led to the development and publication (reference 6) of the revised Bethesda guidelines.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asad Umar.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

DATABASES

Cancer.gov

colorectal cancer

endometrial cancer

LocusLink

APC

BAX

IGF2R

MLH1

MSH2

MSH3

MSH6

PMS1

PMS2

TCF4

TGF-βRII

OMIM

familial adenomatous polyposis

hereditary non-polyposis colorectal cancer

Rights and permissions

Reprints and permissions

About this article

Cite this article

Umar, A., Risinger, J., Hawk, E. et al. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 4, 153–158 (2004). https://doi.org/10.1038/nrc1278

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrc1278

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing